Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Generex Biotechnology Corp GNBTQ

Healthcare Biotechnology
Generex Biotechnology Corp is a Biotechnology company which is primarily engaged in the research and development of drug delivery systems and technologies. It mainly focuses on developing technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator. The company operates in the single segment being the Research and... see more

Recent & Breaking News (EXPM:GNBTQ)

Generex Announces Appointment of Executive Management Team

Business Wire November 15, 2018

Generex Revises Record & Payment Dates for 20:1 Stock Dividend

Business Wire November 14, 2018

Generex Publishes Update to Pending 20:1 Stock Dividend

Business Wire November 13, 2018

Generex Addresses the Opioid Crisis; Provides Proven, Non-Opioid Pain Management Solutions

Business Wire November 7, 2018

GNBT - Goldman Small Cap Research Issues Research Report on Generex Biotechnology Corp. and Interview with its CEO

GlobeNewswire November 5, 2018

Generex Announces REVISED Record & Payment Dates for 20:1 Stock Dividend

Business Wire November 5, 2018

Generex Biotechnology Finalizes Acquisition of Remaining Veneto Operating Assets

Business Wire November 2, 2018

Generex Biotechnology Announces Record & Payment Dates for 20:1 Stock Dividend

Business Wire October 31, 2018

Scientus Pharma Provides Update on Buccal Cannabis Development Program

GlobeNewswire October 31, 2018

Generex Biotechnology Announces IND Filing for a Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda®) for the Treatment of Triple-Negative Breast Cancer

Business Wire October 29, 2018

Generex Confirms & Clarifies 20:1 Common Stock Dividend

Business Wire October 22, 2018

Generex Announces Launch of NuGenerex Distribution Solutions

Business Wire October 17, 2018

Generex Announces Anthony S. Crisci, Esq., CPA as General Manager, Chief Compliance Officer and Corporate Counsel of its New, Wholly-Owned Subsidiary, NuGenerex Distribution Solutions

Business Wire October 12, 2018

Generex Announces Stock Dividend

Business Wire October 10, 2018

Generex Announces Closing of First Tranche Acquisition of Operating Assets

Business Wire October 9, 2018

Generex Biotechnology Corporation Shareholder Alert

Business Wire October 4, 2018

Generex Launches NuGenerex Medical Marketing

Business Wire September 26, 2018

Generex Subsidiary Hema Diagnostic Systems, LLC dba NuGenerex Diagnostics Announces Filing of a European CE Marking Application

Business Wire September 20, 2018

Generex Biotechnology to Present Overview of Immuno-Oncology Development Program at Summit in Boston, MA

Business Wire August 27, 2018

Generex Biotechnology Corporation Announces the Filing of a Patent for its New Diagnostic Point-of-Care Platform, the Express II

Business Wire July 2, 2018